Spatial omics market

Spatial Omics Market, By Technology Type (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), By Product Type (Instruments, Consumables, Software), By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis), By Sample Type (FFPE, Fresh Frozen), By End User (Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Request Free Sample

Mar 2024
CMI5186
160 Pages
Excel & Pdf
Biotechnology

Summary

Omics is a term brief for various diverse studies which includes genomics, transcriptomics, proteomics and metabolomics. The traditional transcriptomics and proteomics approaches have provided insight into disease progression by identifying discrete cellular subpopulation or micro environmental signatures characteristics of normal or pathological tissues. The spatial pattern of the genome have been identified for the treatment of various diseases because of that spatial information is being used as a diagnostic biomarker for identifying the medical condition. Special omics combines molecular analysis with spatial information on the cells localization within the tissue. Thus, this technology is providing a powerful tool to understand important mechanisms such as tissue organisation or cell regulation.

Global spatial omics market is estimated to be valued at USD 315.5 Mn in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031).

Figure 1. Global Spatial Omics Market Value (US$ Mn), By Regional Insights, 2024

Increasing cancer population worldwide is expected to drive growth of the global spatial omics market over the forecast period.

For instance, according to World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. There were 1.41 million cases of prostate cancer worldwide.

Spatial Omics Market Report Coverage

Report Coverage	Details
Base Year:	2023	Market Size in 2024:	US$ 315.5 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.4%	2031 Value Projection:	US$ 591.5 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Technology Type: Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics By Product Type: Instruments, Consumables, Software By Workflow: Sample Preparation, Instrumental Analysis, Data Analysis By Sample Type: FFPE, Fresh Frozen By End User: Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies
Companies covered:	10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode
Growth Drivers:	With Increasing cancer population there is need of advanced technologies for the drug discovery and development. With genomic and transcriptomics drug development process can be accelerated.
Restraints & Challenges:	Limited research expertise are available. Less skilled workforce.

Figure 2. Global Spatial Omics Market Share (%), By Product Type, 2024

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in August 2021, vizgen, the life science company dedicated to improving human health by visualizing single cell spatial genomics information has commercialized MERSCOPE platform, MERSCOPE is the only platform for MERFISH technology. MERFISH provides the highest detection efficacy available for spatially profiling gene expression across whole tissues and resolving individual transcripts with nanometre scale resolution through combinatorial labelling, sequential imaging, and error robust barcoding.

Moreover, in March 2021, Veranome Biosystems LLC, has revealed the world first complete sample to insight high plex spatial omics solution for single cell level characterization. The Pisces technology has been demonstrated to map thousands of custom gene panels in tissues at sub cellular resolution with high gene counts per cell and high sensitivity.

Recent Developments

In November 2023, Stellaromics, a premier provider of in situ spatial multi-omics technology, announced the successful completion of its Series A funding round, securing US$ 25 million. This funding round saw participation from Plaisance Capital Management and a prominent Silicon Valley-based private family office, highlighting strong investor confidence in the company's innovative approach to spatial multi-omics technology.

In June 2023, OWKIN and 10x Genomics, Inc., a leading techbio company, announced that it had signed a deal to integrate 10x Genomics spatial omics and single-cell technologies into the ambitious MOSAIC project. This project has garnered acclaim for its pioneering efforts in tumor analysis aimed at advancing therapeutic discovery.

In December 2021, Rebus Biosystems, Inc., a life science technology company, revealed its acquisition of EEL Transcriptomics AB's intellectual property and associated assay assets. EEL Transcriptomics AB, a privately held enterprise specializing in high-plex spatial transcriptomics with single-cell resolution, has been the focus of this acquisition. The specific terms of the transaction have not been disclosed.

In March 2021, Rebus Biosystems, Inc. announced the launch of the Rebus Esper spatial omics platform. This cutting-edge platform empowers researchers to delve deeper into tissue biology, facilitating advancements in various fields such as neurology, oncology, infectious diseases, and immunology.

Global Spatial Omics Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193,657,725 cases and 4,154,660 deaths due to coronavirus disease (COVID-19) were reported till July 25, 2021, across the globe.

Covid-19 did have negative impact on spatial omics market in early days of covid-19 spread, with decline in the company’s revenue in the second quarter of 2020, due to widespread customer lab closures due to lockdown. However, the impact did not last longer and company’s revenue increased gradually due to increase in consumables revenue driven by growth in instrument installed base.

For instance, the revenue of 10x Genomics of the fourth quarter of 2020 was 112.2 million with 49% increase in the revenue which was 75.3 in the third quarter.

Global Spatial Omics Market Restraint

Spatial omics is relatively new area of research, the global development of spatial transcriptomics research has been concentrated in the U.S and other developed countries. Moreover limited research expertise is available in this field and lack of skilled professionals.

Key Players

Major players operating in the global spatial omics market include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics.

Table of Content

Table of Contents

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Global Spatial Omics Market – Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
Impact on Clinical Trials
Government Initiatives

Global Spatial Omics Market, By Technology Type, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends

Spatial Proteomics

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Spatial Transcriptomics

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Spatial Genomics

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Global Spatial Omics Market, By Product Type, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends

Instruments

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Consumables

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Software

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Global Spatial Omics Market, By Workflow, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends

Sample Preparation

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Instrumental Analysis

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Data Analysis

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Global Spatial Omics Market, By Sample Type, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends

FFPE

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Fresh Frozen

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Global Spatial Omics Market, By End User, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends

Academics & Translational Research Institutes

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Pharmaceutical & Biotechnology Companies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (US$ Mn)

Global Spatial Omics Market, By Region, 2019 – 2031, (US$ Mn)

Introduction

Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2031

North America

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

U.S.
Canada

Latin America

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

GCC
Israel
Rest of Middle East

Africa

Market Size and Forecast, By Technology Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Product Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Workflow, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Sample Type, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By End User, 2019 – 2031, (US$ Mn)
Market Size and Forecast, By Country, 2019 – 2031, (US$ Mn)

South Africa
Central Africa
North Africa

Competitive Landscape

Heat Map Analysis
Market Share Analysis

10x Genomics

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Akoya Bioscience Inc

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Biognosys AG

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

BioSpyder Technologies

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Bio-Techne

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Bruker

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Brooks Automation Inc

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Danaher Corporation

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Diagenode Diagnostics

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Fluidigm Corporation

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

IonPath Inc

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Millennium Science Pty Ltd

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

NanoString Technologies

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

PerkinElmer

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Rebus Biosystems

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Ultivue Inc

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Vizgen Corp

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Dovetail Genomics

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

S2 Genomics, Inc

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Seven Bridges Genomics

Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

Section

References
Research Methodology
About Us and Sales Contact

*Browse 53 market data tables and 38 figures on "Spatial Omics Market” - Global forecast to 2031.

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2024-2031)?

The global spatial omics market size is estimated to be valued at USD 315.5 Mn in 2024 and is expected to exhibit a CAGR of 9.4% between 2024 and 2031.

What are the major factors driving the market growth?

Lately, spatial omics has shifted from strictly research application to drug discovery & development application. Genomics and transcriptomics are major tools for accelerating drug discovery and development processes. With the rapidly increasing global burden of cancer, there is a need for advanced technologies for drug discovery and development.

Which is the leading product type segment in the market?

Instruments is the leading product type segment in the market.

What are the key factors hampering growth of the market?

Limited research expertise and lack of skilled workforce are hampering the growth of the market.

Which are the major players operating in the market?

Major players operating in the market include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics.